A new nomogram to predict pathologic outcome following radical prostatectomy
OBJECTIVE: To develop a preoperative nomogram to predict pathologic outcome in patients submitted to radical prostatectomy for clinical localized prostate cancer. MATERIALS AND METHODS: Nine hundred and sixty patients with clinical stage T1 and T2 prostate cancer were evaluated following radical prostatectomy, and 898 were included in the study. Following a multivariate analysis, nomograms were developed incorporating serum PSA, biopsy Gleason score, and percentage of positive biopsy cores in order to predict the risks of extraprostatic tumor extension, and seminal vesicle involvement. RESULTS: In univariate analysis there was a significant association between percentage of positive biopsy cores (p < 0.001), serum PSA (p = 0.001) and biopsy Gleason score (p < 0.001) with extraprostatic tumor extension. A similar pathologic outcome was seen among tumors with Gleason score 7, and Gleason score 8 to 10. In multivariate analysis, the 3 preoperative variables showed independent significance to predict tumor extension. This allowed the development of nomogram-1 (using Gleason scores in 3 categories - 2 to 6, 7 and 8 to 10) and nomogram-2 (using Gleason scores in 2 categories - 2 to 6 and 7 to 10) to predict disease extension based on these 3 parameters. In the validation analysis, 87% and 91.1% of the time the nomograms-1 and 2, correctly predicted the probability of a pathological stage to within 10% respectively. CONCLUSION: Incorporating percent of positive biopsy cores to a nomogram that includes preoperative serum PSA and biopsy Gleason score, can accurately predict the presence of extraprostatic disease extension in patients with clinical localized prostate cancer.
Main Authors: | , , , , , , |
---|---|
Format: | Digital revista |
Language: | English |
Published: |
Sociedade Brasileira de Urologia
2006
|
Online Access: | http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1677-55382006000200005 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
id |
oai:scielo:S1677-55382006000200005 |
---|---|
record_format |
ojs |
spelling |
oai:scielo:S1677-553820060002000052006-06-08A new nomogram to predict pathologic outcome following radical prostatectomyCrippa,AlexandreSrougi,MiguelDallOglio,Marcos F.Antunes,Alberto A.Leite,Katia R.Nesrallah,Luciano J.Ortiz,Valdemar prostatic neoplasms neoplasm staging nomograms prostate-specific antigen needle biopsy OBJECTIVE: To develop a preoperative nomogram to predict pathologic outcome in patients submitted to radical prostatectomy for clinical localized prostate cancer. MATERIALS AND METHODS: Nine hundred and sixty patients with clinical stage T1 and T2 prostate cancer were evaluated following radical prostatectomy, and 898 were included in the study. Following a multivariate analysis, nomograms were developed incorporating serum PSA, biopsy Gleason score, and percentage of positive biopsy cores in order to predict the risks of extraprostatic tumor extension, and seminal vesicle involvement. RESULTS: In univariate analysis there was a significant association between percentage of positive biopsy cores (p < 0.001), serum PSA (p = 0.001) and biopsy Gleason score (p < 0.001) with extraprostatic tumor extension. A similar pathologic outcome was seen among tumors with Gleason score 7, and Gleason score 8 to 10. In multivariate analysis, the 3 preoperative variables showed independent significance to predict tumor extension. This allowed the development of nomogram-1 (using Gleason scores in 3 categories - 2 to 6, 7 and 8 to 10) and nomogram-2 (using Gleason scores in 2 categories - 2 to 6 and 7 to 10) to predict disease extension based on these 3 parameters. In the validation analysis, 87% and 91.1% of the time the nomograms-1 and 2, correctly predicted the probability of a pathological stage to within 10% respectively. CONCLUSION: Incorporating percent of positive biopsy cores to a nomogram that includes preoperative serum PSA and biopsy Gleason score, can accurately predict the presence of extraprostatic disease extension in patients with clinical localized prostate cancer.info:eu-repo/semantics/openAccessSociedade Brasileira de UrologiaInternational braz j urol v.32 n.2 20062006-04-01info:eu-repo/semantics/articletext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S1677-55382006000200005en10.1590/S1677-55382006000200005 |
institution |
SCIELO |
collection |
OJS |
country |
Brasil |
countrycode |
BR |
component |
Revista |
access |
En linea |
databasecode |
rev-scielo-br |
tag |
revista |
region |
America del Sur |
libraryname |
SciELO |
language |
English |
format |
Digital |
author |
Crippa,Alexandre Srougi,Miguel DallOglio,Marcos F. Antunes,Alberto A. Leite,Katia R. Nesrallah,Luciano J. Ortiz,Valdemar |
spellingShingle |
Crippa,Alexandre Srougi,Miguel DallOglio,Marcos F. Antunes,Alberto A. Leite,Katia R. Nesrallah,Luciano J. Ortiz,Valdemar A new nomogram to predict pathologic outcome following radical prostatectomy |
author_facet |
Crippa,Alexandre Srougi,Miguel DallOglio,Marcos F. Antunes,Alberto A. Leite,Katia R. Nesrallah,Luciano J. Ortiz,Valdemar |
author_sort |
Crippa,Alexandre |
title |
A new nomogram to predict pathologic outcome following radical prostatectomy |
title_short |
A new nomogram to predict pathologic outcome following radical prostatectomy |
title_full |
A new nomogram to predict pathologic outcome following radical prostatectomy |
title_fullStr |
A new nomogram to predict pathologic outcome following radical prostatectomy |
title_full_unstemmed |
A new nomogram to predict pathologic outcome following radical prostatectomy |
title_sort |
new nomogram to predict pathologic outcome following radical prostatectomy |
description |
OBJECTIVE: To develop a preoperative nomogram to predict pathologic outcome in patients submitted to radical prostatectomy for clinical localized prostate cancer. MATERIALS AND METHODS: Nine hundred and sixty patients with clinical stage T1 and T2 prostate cancer were evaluated following radical prostatectomy, and 898 were included in the study. Following a multivariate analysis, nomograms were developed incorporating serum PSA, biopsy Gleason score, and percentage of positive biopsy cores in order to predict the risks of extraprostatic tumor extension, and seminal vesicle involvement. RESULTS: In univariate analysis there was a significant association between percentage of positive biopsy cores (p < 0.001), serum PSA (p = 0.001) and biopsy Gleason score (p < 0.001) with extraprostatic tumor extension. A similar pathologic outcome was seen among tumors with Gleason score 7, and Gleason score 8 to 10. In multivariate analysis, the 3 preoperative variables showed independent significance to predict tumor extension. This allowed the development of nomogram-1 (using Gleason scores in 3 categories - 2 to 6, 7 and 8 to 10) and nomogram-2 (using Gleason scores in 2 categories - 2 to 6 and 7 to 10) to predict disease extension based on these 3 parameters. In the validation analysis, 87% and 91.1% of the time the nomograms-1 and 2, correctly predicted the probability of a pathological stage to within 10% respectively. CONCLUSION: Incorporating percent of positive biopsy cores to a nomogram that includes preoperative serum PSA and biopsy Gleason score, can accurately predict the presence of extraprostatic disease extension in patients with clinical localized prostate cancer. |
publisher |
Sociedade Brasileira de Urologia |
publishDate |
2006 |
url |
http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1677-55382006000200005 |
work_keys_str_mv |
AT crippaalexandre anewnomogramtopredictpathologicoutcomefollowingradicalprostatectomy AT srougimiguel anewnomogramtopredictpathologicoutcomefollowingradicalprostatectomy AT dallogliomarcosf anewnomogramtopredictpathologicoutcomefollowingradicalprostatectomy AT antunesalbertoa anewnomogramtopredictpathologicoutcomefollowingradicalprostatectomy AT leitekatiar anewnomogramtopredictpathologicoutcomefollowingradicalprostatectomy AT nesrallahlucianoj anewnomogramtopredictpathologicoutcomefollowingradicalprostatectomy AT ortizvaldemar anewnomogramtopredictpathologicoutcomefollowingradicalprostatectomy AT crippaalexandre newnomogramtopredictpathologicoutcomefollowingradicalprostatectomy AT srougimiguel newnomogramtopredictpathologicoutcomefollowingradicalprostatectomy AT dallogliomarcosf newnomogramtopredictpathologicoutcomefollowingradicalprostatectomy AT antunesalbertoa newnomogramtopredictpathologicoutcomefollowingradicalprostatectomy AT leitekatiar newnomogramtopredictpathologicoutcomefollowingradicalprostatectomy AT nesrallahlucianoj newnomogramtopredictpathologicoutcomefollowingradicalprostatectomy AT ortizvaldemar newnomogramtopredictpathologicoutcomefollowingradicalprostatectomy |
_version_ |
1756427975292616704 |